Which antimicrobial treatment for patients with bloodstream infection during ECMO support?
Nicolas Massart(Centre Hospitalier de Saint-Brieuc), Charles‐Édouard Luyt(Inserm), Charles Vidal(Centre Hospitalier Universitaire de La Réunion), Benjamin Assouline(University of Geneva), Francesca Manicone(Université Libre de Bruxelles), Adrien Bouglé(Sorbonne Université), Frank Bidar(Université Claude Bernard Lyon 1), Samuel Henri(Centre Hospitalier Universitaire de Lille), Étienne de Montmollin(Inserm), Sofia Ortuno(Centre Hospitalier Universitaire de Nantes), Sami Hraiech(Assistance Publique Hôpitaux de Marseille), Paul Masi(Associated Research (United States)), Nicolas Nesseler(Inserm), Hadrien Rozé(Université de Bordeaux)
European Journal of Clinical Microbiology & Infectious Diseases
February 8, 2025
Cited by 2
Related Papers
Ventilator-associated pneumonia in adults: a narrative review
|Intensive Care Medicine|2020|995
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
|Science Immunology|2021|638
Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study
|The Lancet Respiratory Medicine|2020|477
Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: a European multicenter cohort study
|Intensive Care Medicine|2021|421
Predictors of successful extracorporeal membrane oxygenation (ECMO) weaning after assistance for refractory cardiogenic shock
|Intensive Care Medicine|2011|356